More evidence on fracture risk associated with thiazolidinediones

2 May 2008 Print this article Comments Share this article
Two new reports have confirmed an increased risk of non-vertebral osteoporotic fractures in patients with type 2 diabetes treated with pioglitazone or rosiglitazone....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites